TIGIT and cutaneous melanoma: Similarly, TIGIT expression was shown to be epigenetically regulated via DNA methylation in skin melanoma, suggesting that TIGIT DNA methylation and expression may serve as predictive biomarkers in the context of immunotherapies [48].